Ninety One, Inc. Partners with the Multi-Scale Robotics Lab at ETH Zurich to Advance Robotic Surgery


Reading time ( words)

The Multi-Scale Robotics Lab (MSRL) at ETH Zurich and Ninety One, Inc., have partnered to advance Precision Medicine and Surgical Robotics through advanced Artificial Intelligence and Machine Learning.

“Ninety One has five priority areas that will be core to our near and long-term growth and that will define the future of Digital Health; Personalized Patient Care, Precision Diagnostics, Robotic Surgery, Image Guided Therapy, and Connected Care Delivery. We are proactively teaming up centers of innovation globally to identify ways to improve patient outcomes, quality of care delivery, and cost productivity, all centered around the Quadruple Aim in medicine. We are delighted to have the opportunity to work with Prof. Bradley Nelson, Christophe Chautems and their medical robotics team at ETH Zurich.” said Bleron Baraliu CEO Ninety One, Inc.

“The combination of the remote magnetic navigation systems designed at MSRL with machine learning algorithms will open new opportunities to improve the outcome of multiple medical procedures,” said Christophe Chautems, Group Leader Medical Robotics at ETH Zurich.

Share

Print


Suggested Items

Enabling Revolutionary Nondestructive Inspection Capability

06/17/2019 | DARPA
X-rays and gamma rays have a wide range of applications including scanning suspicious maritime shipping containers for illicit materials, industrial inspection of materials and processes, and medical diagnostic and therapeutic procedures.

Wearable Tech Back to a Healthy Development Pace

02/11/2015 | Reed Exhibitions
Wearable tech was a major sensation in 2014. The wearable tech industry generated extensive interest among media, investors, start-ups, wearable tech enthusiasts, technology leaders and trade fairs. Many events were held around wearable products and industry last year. The trend for early 2015 has seen the industry fall back into a healthy developmental pace. Investors are keen to see a return on their capital injections and former start-ups are now reaching maturity.



Copyright © 2020 I-Connect007. All rights reserved.